✦ LIBER ✦

Homozygosity for HLA Group 2 Alleles Predicts Treatment Failure with Interferon-α and Ribavirin in Chronic Hepatitis C Virus Genotype 1 Infection

✍ Scribed by Collison, Meadhbh; Chin, Jun Liong; Abu Shanab, Ahmed; Mac Nicholas, Ross; Segurado, Ricardo; Coughlan, Suzie; Connell, Jeff; Carr, Michael J.; Merriman, Raphael B.; McCormick, P. Aiden; Hall, William W.

Book ID: 126721445
Publisher: Mary Ann Liebert
Year: 2015
Tongue: English
Weight: 314 KB
Volume: 35
Category: Article
ISSN: 1079-9907
DOI: 10.1089/jir.2014.0088

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of treatment with interferon α-2b

Effect of treatment with interferon α-2b and ribavirin in patients infected with genotype 2 hepatitis C virus

✍ Yoshihiko Nagase; Hiroshi Yotsuyanagi; Chiaki Okuse; Kiyomi Yasuda; Tomohiro Kat 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 321 KB

Peginterferon α-2b plus ribavirin compar

Peginterferon α-2b plus ribavirin compared with interferon α-2b plus ribavirin for initial treatment of chronic hepatitis C in Saudi patients commonly infected with genotype 4

✍ F. Z. Alfaleh; Q. Hadad; M. S. Khuroo; A. Aljumah; A. Algamedi; H. Alashgar; M. 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB

Pilot study of interferon-α–ribavirin–in

Pilot study of interferon-α–ribavirin–interleukin-2 for treatment of nonresponder patients with severe liver disease infected by hepatitis C virus genotype 1

✍ L. Alric; S. Thebault; J.-M. Peron; P. Balard; S. Metivier; B. Pipy; J. Izopet; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB

Daily dose of interferon alpha-2b and ri

Daily dose of interferon alpha-2b and ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection: a randomised controlled study

✍ GianPiero Benetti; Mauro Borzio; Giuliano Ramella; Giorgio Bellati; Silvia Fargi 📂 Article 📅 2006 🏛 Springer Milan 🌐 English ⚖ 98 KB

Favorable factors for re-treatment with

Favorable factors for re-treatment with pegylated interferon α2a plus ribavirin in patients with high viral loads of genotype 1 hepatitis C virus

✍ Akihiro Tamori; Kiyohide Kioka; Osamu Kurai; Hiroki Sakaguchi; Masaru Enomoto; H 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 543 KB

Prediction of nonSVR to therapy with peg

Prediction of nonSVR to therapy with pegylated interferon-α2a and ribavirin in chronic hepatitis C genotype 1 patients after 4, 8 and 12 weeks of treatment

✍ E. Lukasiewicz; M. Gorfine; L. S. Freedman; J.-M. Pawlotsky; S. W. Schalm; C. Fe 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB